• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TEMBDAI:LX

25.38 USD 0.27 1.08%

As of 00:59:30 ET on 07/09/2014.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TEMBDAI)

Year To Date: +8.88% 3-Month: +3.63% 3-Year: +29.13% 52-Week Range: 19.61 - 28.83
1-Month: +3.38% 1-Year: +31.23% 5-Year: +26.63% Beta vs NBI: 0.99

Mutual Fund Chart for TEMBDAI

No chart data available.
  • TEMBDAI:LX 25.11
  • 1M
  • 1Y
Interactive TEMBDAI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TEMBDAI

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: 04-03-2000 Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.lu

Fundamentals for TEMBDAI

NAV (on 2014-07-09) 25.38
Assets (M) (on 2014-05-31) 2,981.20
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 1,000.00

Dividends for TEMBDAI

No dividends reported

Fees & Expenses for TEMBDAI

Front Load 5.75
Back Load 1.00
Current Mgmt Fee 1.00
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.82

Top Fund Holdings for TEMBDAI

Filing Date: 04/30/2014
Name Position Value % of Total
Gilead Sciences Inc 4,065,000 319,061,850 10.929%
Biogen Idec Inc 774,540 222,385,925 7.618%
Amgen Inc 1,357,100 151,655,925 5.195%
Celgene Corp 2,005,000 147,377,525 5.048%
Regeneron Pharmaceuticals Inc 492,000 146,069,880 5.003%
Medivation Inc 2,116,100 127,410,381 4.364%
Alexion Pharmaceuticals Inc 567,200 89,731,040 3.074%
Incyte Corp Ltd 1,741,200 84,552,672 2.896%
Illumina Inc 606,400 82,379,440 2.822%
Vertex Pharmaceuticals Inc 1,018,100 68,925,370 2.361%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil